Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
117904465 | 11790446 | 5 | F | 20150522 | 20160826 | 20151201 | 20160912 | EXP | JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-055975 | BRISTOL MYERS SQUIBB | 83.00 | YR | F | Y | 0.00000 | 20160912 | CN | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
117904465 | 11790446 | 1 | PS | NIVOLUMAB | NIVOLUMAB | 1 | Intravenous (not otherwise specified) | 1.8 MG/KG, UNK | 16 | MG/KG | U | 125554 | 1.8 | MG/KG | |||||
117904465 | 11790446 | 2 | SS | NIVOLUMAB | NIVOLUMAB | 1 | Intravenous (not otherwise specified) | 2 MG/KG, UNK | 16 | MG/KG | U | 125554 | 2 | MG/KG | |||||
117904465 | 11790446 | 3 | SS | NIVOLUMAB | NIVOLUMAB | 1 | Intravenous (not otherwise specified) | 2 MG/KG, UNK | 16 | MG/KG | U | 125554 | 2 | MG/KG | |||||
117904465 | 11790446 | 4 | SS | NIVOLUMAB | NIVOLUMAB | 1 | Intravenous (not otherwise specified) | 2 MG/KG, UNK | 16 | MG/KG | U | 125554 | 2 | MG/KG | |||||
117904465 | 11790446 | 5 | SS | NIVOLUMAB | NIVOLUMAB | 1 | Intravenous (not otherwise specified) | 2 MG/KG, UNK | 16 | MG/KG | U | 125554 | 2 | MG/KG | |||||
117904465 | 11790446 | 6 | SS | NIVOLUMAB | NIVOLUMAB | 1 | Intravenous (not otherwise specified) | 2 MG/KG, UNK | 16 | MG/KG | U | 125554 | 2 | MG/KG | |||||
117904465 | 11790446 | 7 | SS | NIVOLUMAB | NIVOLUMAB | 1 | Intravenous (not otherwise specified) | 2 MG/KG, UNK | 16 | MG/KG | U | 125554 | 2 | MG/KG | |||||
117904465 | 11790446 | 8 | SS | NIVOLUMAB | NIVOLUMAB | 1 | Intravenous (not otherwise specified) | 2 MG/KG, UNK | 16 | MG/KG | U | 125554 | 2 | MG/KG | |||||
117904465 | 11790446 | 9 | SS | NIVOLUMAB | NIVOLUMAB | 1 | Intravenous (not otherwise specified) | 2 MG/KG, UNK | 16 | MG/KG | U | 125554 | 2 | MG/KG | |||||
117904465 | 11790446 | 10 | SS | NIVOLUMAB | NIVOLUMAB | 1 | Intravenous (not otherwise specified) | 2 MG/KG, UNK | 16 | MG/KG | U | 125554 | 2 | MG/KG | |||||
117904465 | 11790446 | 11 | SS | NIVOLUMAB | NIVOLUMAB | 1 | Intravenous (not otherwise specified) | 2 MG/KG, UNK | 16 | MG/KG | U | 125554 | 2 | MG/KG | |||||
117904465 | 11790446 | 12 | SS | NIVOLUMAB | NIVOLUMAB | 1 | Intravenous (not otherwise specified) | 2 MG/KG, UNK | 16 | MG/KG | U | 125554 | 2 | MG/KG | |||||
117904465 | 11790446 | 13 | SS | NIVOLUMAB | NIVOLUMAB | 1 | Intravenous drip | 2 MG/KG, UNK | 16 | MG/KG | U | 125554 | 2 | MG/KG | |||||
117904465 | 11790446 | 14 | SS | NIVOLUMAB | NIVOLUMAB | 1 | Intravenous drip | 2 MG/KG, UNK | 16 | MG/KG | U | 125554 | 2 | MG/KG | |||||
117904465 | 11790446 | 15 | SS | NIVOLUMAB | NIVOLUMAB | 1 | Intravenous drip | 2 MG/KG, UNK | 16 | MG/KG | U | 125554 | 2 | MG/KG | |||||
117904465 | 11790446 | 16 | SS | NIVOLUMAB | NIVOLUMAB | 1 | Intravenous drip | 2 MG/KG, UNK | 16 | MG/KG | U | 125554 | 2 | MG/KG | |||||
117904465 | 11790446 | 17 | SS | PREDNISOLONE /00016202/ | PREDNISOLONE | 1 | Unknown | 4 MG, QD | U | 0 | 4 | MG | QD | ||||||
117904465 | 11790446 | 18 | SS | PREDNISOLONE /00016202/ | PREDNISOLONE | 1 | Unknown | 20 MG, QD | U | 0 | 20 | MG | QD | ||||||
117904465 | 11790446 | 19 | SS | PREDNISOLONE /00016202/ | PREDNISOLONE | 1 | Unknown | 15 MG, QD | U | 0 | 15 | MG | QD | ||||||
117904465 | 11790446 | 20 | SS | PREDNISOLONE /00016202/ | PREDNISOLONE | 1 | Unknown | 10 MG, QD | U | 0 | 10 | MG | QD | ||||||
117904465 | 11790446 | 21 | SS | PREDNISOLONE /00016202/ | PREDNISOLONE | 1 | Unknown | 7.5 MG, QD | U | 0 | 7.5 | MG | QD | ||||||
117904465 | 11790446 | 22 | SS | PREDNISOLONE /00016202/ | PREDNISOLONE | 1 | Unknown | 5 MG, QD | U | 0 | 5 | MG | QD | ||||||
117904465 | 11790446 | 23 | SS | SULFAMETHOXAZOLE AND TRIMETHOPRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Unknown | U | 0 | ||||||||||
117904465 | 11790446 | 24 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Unknown | U | 0 | ||||||||||
117904465 | 11790446 | 25 | SS | ADALAT | NIFEDIPINE | 1 | Unknown | U | 0 | ||||||||||
117904465 | 11790446 | 26 | SS | BONALON | ALENDRONATE SODIUM | 1 | Unknown | U | 0 | ||||||||||
117904465 | 11790446 | 27 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Unknown | U | 0 | ||||||||||
117904465 | 11790446 | 28 | SS | PURSENNID /00142207/ | SENNOSIDES A AND B | 1 | Unknown | U | 0 | ||||||||||
117904465 | 11790446 | 29 | SS | THYRADIN | LEVOTHYROXINE | 1 | Unknown | U | 0 | ||||||||||
117904465 | 11790446 | 30 | SS | MUCODYNE | CARBOCYSTEINE | 1 | Unknown | U | 0 | ||||||||||
117904465 | 11790446 | 31 | SS | MAGMITT | MAGNESIUM OXIDE | 1 | Unknown | U | 0 | ||||||||||
117904465 | 11790446 | 32 | SS | MEILAX | ETHYL LOFLAZEPATE | 1 | Unknown | U | 0 | ||||||||||
117904465 | 11790446 | 33 | SS | CALONAL | ACETAMINOPHEN | 1 | Unknown | U | 0 | ||||||||||
117904465 | 11790446 | 34 | SS | TENELIA | TENELIGLIPTIN | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
117904465 | 11790446 | 1 | Malignant melanoma |
117904465 | 11790446 | 17 | Product used for unknown indication |
117904465 | 11790446 | 23 | Product used for unknown indication |
117904465 | 11790446 | 24 | Product used for unknown indication |
117904465 | 11790446 | 25 | Product used for unknown indication |
117904465 | 11790446 | 26 | Product used for unknown indication |
117904465 | 11790446 | 27 | Product used for unknown indication |
117904465 | 11790446 | 28 | Product used for unknown indication |
117904465 | 11790446 | 29 | Product used for unknown indication |
117904465 | 11790446 | 30 | Product used for unknown indication |
117904465 | 11790446 | 31 | Product used for unknown indication |
117904465 | 11790446 | 32 | Product used for unknown indication |
117904465 | 11790446 | 33 | Product used for unknown indication |
117904465 | 11790446 | 34 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
117904465 | 11790446 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
117904465 | 11790446 | Blood corticotrophin decreased | |
117904465 | 11790446 | Nephrotic syndrome | |
117904465 | 11790446 | Prescribed underdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
117904465 | 11790446 | 1 | 20150522 | 20150522 | 0 | |
117904465 | 11790446 | 2 | 20150611 | 20150611 | 0 | |
117904465 | 11790446 | 3 | 20150706 | 20150706 | 0 | |
117904465 | 11790446 | 4 | 20150729 | 20150729 | 0 | |
117904465 | 11790446 | 5 | 20150821 | 20150821 | 0 | |
117904465 | 11790446 | 6 | 20150911 | 20150911 | 0 | |
117904465 | 11790446 | 7 | 20151002 | 20151002 | 0 | |
117904465 | 11790446 | 8 | 20151023 | 20151023 | 0 | |
117904465 | 11790446 | 9 | 20151113 | 20151113 | 0 | |
117904465 | 11790446 | 10 | 20151204 | 20151204 | 0 | |
117904465 | 11790446 | 11 | 20151225 | 20151225 | 0 | |
117904465 | 11790446 | 12 | 20160115 | 20160115 | 0 | |
117904465 | 11790446 | 13 | 20160205 | 20160205 | 0 | |
117904465 | 11790446 | 14 | 20160226 | 20160226 | 0 | |
117904465 | 11790446 | 15 | 20160318 | 20160318 | 0 | |
117904465 | 11790446 | 16 | 20160408 | 20160408 | 0 | |
117904465 | 11790446 | 18 | 20151113 | 0 | ||
117904465 | 11790446 | 19 | 20151207 | 0 | ||
117904465 | 11790446 | 20 | 20151221 | 0 | ||
117904465 | 11790446 | 21 | 20160119 | 0 | ||
117904465 | 11790446 | 22 | 20160209 | 0 |